Publications by authors named "Nicholas M Kelly"

Claim this Profile
A
A high-throughput assay identifies molecules with antimicrobial activity against persister cells.
Maiken Engelbrecht Petersen, Liva Kjær Hansen, Alexander Alexandrovich Mitkin, Nicholas M Kelly, Thomas Keith Wood

J Med Microbiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.
Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk, Marianne Skals, Anders Riisager, Nicholas M Kelly

Sci Transl Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
Matthias Holdhoff, M Kelly Nicholas, Richard A Peterson, Stefania Maraka, Li C Liu

Neurooncol Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Oana C Danciu, Matthias Holdhoff, Richard A Peterson, James H Fischer, Li C Liu, M Kelly Nicholas

Br J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Karan S Dixit, Sean Sachdev, Christina Amidei, Priya Kumthekar, Tim J Kruser, Martin Kelly Nicholas

J Neurooncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.
Lijie Zhai, Mahua Dey, Kristen L Lauing, Galina Gritsina, Rajwant Kaur, M Kelly Nicholas

J Clin Neurosci· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical neuro-oncology formal education opportunities for medical students in the United States and Canada.
Karan S Dixit, Martin Kelly Nicholas, Rimas V Lukas

World Neurosurg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of radiation necrosis of the central nervous system treated with bevacizumab.
Karen Tye, Herbert H Engelhard, Konstantin V Slavin, M Kelly Nicholas, Steven J Chmura

J Neurooncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update in the treatment of high-grade Gliomas.
Rimas V Lukas, Martin Kelly Nicholas

Neurol Clin· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of Esaprazole analogues showing σ1 binding and neuroprotective properties in vitro.
Nicholas M Kelly, Anja Wellejus, Heidi Elbrønd-Bek, Morten Sloth Weidner, Signe Humle Jørgensen

Bioorg Med Chem· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective audit of the efficacy, safety, and acceptability of low-volume polyethylene glycol (2 L) versus standard volume polyethylene glycol (4 L) versus magnesium citrate plus stimulant laxative as bowel preparation for colonoscopy.
Nicholas Michael Kelly, Colin Rodgers, Neil Patterson, Sudheer George Jacob, Inder Mainie

J Clin Gastroenterol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-iodophenyl isothiocyanate: a neuroprotective compound.
Anja Wellejus, Heidi Elbrønd-Bek, Nicholas M Kelly, Morten S Weidner, Signe H Jørgensen

Restor Neurol Neurosci· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of continuous infusion cilengitide in patients with solid tumors.
Peter H O'Donnell, Samir D Undevia, Walter M Stadler, Theodore M Karrison, M Kelly Nicholas

Invest New Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.
Rimas V Lukas, Martin Kelly Nicholas, Victoria Villaflor, Philip C Hoffman, Ravi Salgia

J Neurol Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
M Kelly Nicholas, Rimas V Lukas, Steven Chmura, Bakhtihar Yamini, Maciej Lesniak

Semin Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.
Jeffrey J Raizer, Sean Grimm, Marc C Chamberlain, M Kelly Nicholas, James P Chandler

Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ immobilization of palladium nanoparticles in microfluidic reactors and assessment of their catalytic activity.
Rui Lin, Ruel G Freemantle, Nicholas M Kelly, Thomas R Fielitz, Sherine O Obare

Nanotechnology· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the 'driving test' a robust quality indicator of colonoscopy performance?
Nicholas M Kelly, John Moorehead, Tony Tham

World J Gastrointest Endosc· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.
Gilles Gaubert, Fabio Bertozzi, Nicholas M Kelly, Jan Pawlas, Audra L Scully

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
Leila Malik, Nicholas M Kelly, Jian-Nong Ma, Erika A Currier, Ethan S Burstein

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in the treatment of malignant gliomas.
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas

Onco Targets Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful endoscopic management of fractured Dormia basket during endoscopic retrograde cholangiopancreatography for choledocholithiasis.
Nicholas M Kelly, Grant R Caddy

Ulster Med J· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma multiforme: evidence-based approach to therapy.
M Kelly Nicholas

Expert Rev Anticancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for malignant glioma.
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas

Expert Rev Anticancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
M Kelly Nicholas, Rimas V Lukas, Nazia F Jafri, Leonardo Faoro, Ravi Salgia

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis